Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$1.56 - $1.98 $30,683 - $38,944
-19,669 Reduced 48.0%
21,308 $36,000
Q4 2020

Feb 12, 2021

SELL
$0.75 - $2.76 $34 - $126
-46 Reduced 0.11%
40,977 $61,000
Q3 2020

Nov 13, 2020

SELL
$0.61 - $1.17 $4,540 - $8,708
-7,443 Reduced 15.36%
41,023 $39,000
Q2 2020

Aug 13, 2020

BUY
$0.47 - $0.72 $2,910 - $4,458
6,193 Added 14.65%
48,466 $32,000
Q1 2020

May 11, 2020

BUY
$0.36 - $0.74 $8,073 - $16,595
22,426 Added 112.99%
42,273 $18,000
Q3 2019

Nov 14, 2019

BUY
$0.38 - $0.52 $1,924 - $2,633
5,065 Added 34.26%
19,847 $10,000
Q2 2019

Aug 20, 2019

BUY
$0.39 - $0.7 $5,764 - $10,347
14,782 New
14,782 $6,000
Q3 2018

Nov 14, 2018

SELL
$0.44 - $3.02 $13,030 - $89,437
-29,615 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.16 - $3.48 $38,063 - $61,324
17,622 Added 146.94%
29,615 $101,000
Q3 2017

Nov 15, 2017

BUY
$0.38 - $0.66 $4,557 - $7,915
11,993
11,993 $7,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.